(Q34326826)

1 August 2017

1 reference

title

The molecular biology of cervical cancer. (English)

1 reference

1 August 2017

0 references

cervix uterine cancer

1 reference

Wolf JK

1 reference

1 August 2017

Ramirez PT

series ordinal

1 reference

1 August 2017

publication date

1 January 2001

1 reference

1 August 2017

1 reference

1 August 2017

1 reference

1 August 2017

1 reference

1 August 2017

page(s)

621-629

1 reference

Molecular themes in oncogenesis

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100104290

A binary (Bethesda) system for classifying cervical cancer precursors: criteria, reproducibility, and viral correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100104290

Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100104290

p53 mutations in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100104290

p53 mutations in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100104290

The p53 tumour suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100104290

Association of human papillomavirus types 16 and 18 E6 proteins with p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100104290

Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100104290

Human papillomavirus infection and TP53 gene mutation in primary cervical carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100104290

Clonal p53 mutation in primary cervical cancer: association with human-papillomavirus-negative tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100104290

The multistep nature of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100104290

Phosphorylation of the retinoblastoma protein by cdk2

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100104290

The retinoblastoma protein and cell cycle control

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100104290

The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100104290

The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100104290

Interaction between the retinoblastoma protein and the oncoprotein MDM2

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100104290

HPV-associated cervical cancers show frequent allelic loss at 3p14 but no apparent aberration of FHIT mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100104290

Cervical intraepithelial neoplasia III shows frequent allelic loss in 3p and 6p.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100104290

The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100104290

Genetic and biochemical dissection of protein linkages in the cadherin-catenin complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100104290

Loss of heterozygosity for defined regions on chromosomes 3, 11 and 17 in carcinomas of the uterine cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100104290

Integrated control of cell proliferation and cell death by the c-myc oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100104290

Prognostic value of c-myc proto-oncogene overexpression in early invasive carcinoma of the cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100104290

Amplification of the c-myc proto-oncogene in cervical carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100104290

C-erbB-2 immunostaining: problems with interpretation

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100104290

p21-containing cyclin kinases exist in both active and inactive states

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100104290

Transforming growth factor-beta 1 induces apoptosis through down-regulation of c-myc gene and overexpression of p27Kip1 protein in cervical carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100104290

Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100104290

Prognostic value of bcl-2 expression in patients with operable carcinoma of the uterine cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100104290

Prognostic importance of histologic vascular density in cervical cancer treated with hypertensive intraarterial chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100104290

The roles of the human major histocompatibility complex and human papillomavirus infection in cervical intraepithelial neoplasia and cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100104290

Correlation of T-helper secretory differentiation and types of antigen-presenting cells in squamous intraepithelial lesions of the uterine cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100104290

A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100104290

Growth inhibition of human cervical cancer cells with the recombinant adenovirus p53 in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100104290

Molecular biology of cervical cancer and its precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100104290

Human papillomaviruses associated with cervical intraepithelial neoplasia. Great diversity and distinct distribution in low- and high-grade lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100104290

Aberrant expression of the cell cycle associated proteins TP53, MDM2, p21, p27, cdk4, cyclin D1, RB, and EGFR in cervical carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100104290

Myc protein: partners and antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100104290

C-myc proto-oncogene expression and prognosis in early carcinoma of the uterine cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100104290

c-erbB-2 Oncoprotein and Epidermal Growth Factor Receptor in Cervical Lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100104290

Expression of bcl-2 in invasive and in situ carcinoma of the uterine cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100104290

Cytokine expression in squamous intraepithelial lesions of the uterine cervix: implications for the generation of local immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100104290

21 January 2018

Identifiers

DOI

10.1081/CNV-100104290

1 reference

1 August 2017

1 reference